Metformin in lung cancer: rationale for a combination therapy

Author： Morgillo Floriana Sasso Ferdinando Carlo Della Corte Carminia Maria Festino Lucia Manzo Anna Martinelli Erika Troiani Teresa Capuano Annalisa Ciardiello Fortunato

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.11, 2013-11, pp. : 1401-1409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitagliptin and metformin –– novel combination therapy

By Seyoum Berhane

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 641-646

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy with Metformin and Fenofibrate for Insulin Resistance in Obesity

By Li X-M Li Y Zhang N-N Xie Y-H Shi Y-Q

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1876-1882

Field House Publishing

Access to resources Recommend Favorite

Combination therapy versus single agent chemotherapy in non-small cell lung cancer

By Cheong Kerry Spicer James Chowdhury Simon Harper Peter

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1693-1700

Informa Healthcare

Access to resources Recommend Favorite

Rosiglitazone plus metformin: combination therapy for Type 2 diabetes

By Del Prato Stefano Volpe Laura

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1411-1422

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus

By Guarino Elisa Nigi Laura Patti Aurora Fondelli Cecilia Dotta Francesco

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1377-1384

Informa Healthcare

Access to resources Recommend Favorite